click enter text
 ep beat light revenu revenue guidanc
lower ep intact ibranc us growth neg y/i
report financi result morn revenu
touch light beat ep report revenu vs
estim consensu report ep
vs estim consensu beat
larg driven higher incom lower expect tax rate
guidanc narrow lower narrow lower
revenu guidanc mid-point vs prior
guidanc primarili due continu legaci hospira steril inject
us suppli issu unfavor chang fx narrow non-
gaap ep guidanc mid-point vs prior
ibranc sale vs consensu estim us
growth stall import cancer product sale
vs vs prior sequenti quarter
prevnar sale vs estim consensu
growth fuel primarili due higher govern purchas pediatr
trade fundament data
upsid target
addit detail us/eu drug compani
cover see recent initi report oct global
factset/wolf research price oct
report limit sole use client wolf research pleas refer disclosur section locat end
report analyst certif import disclosur disclosur
page
exhibit show compani report actual result vs estim consensu
exhibit pfizer result vs wr estim consensu
page
